Skip to main content

Table 1 Number of patients in the cohort with cohort with each malignancy type and chemotherapy regimen used

From: Conventional myelosuppressive chemotherapy for non-haematological malignancy disrupts the intestinal microbiome

  No.
Malignancy type
 Breast 4
 Non-small-cell lung cancer 4
 Pancreatic 2
 Bladder 1
 Cholangiocarcinoma 1
 Endometrial 1
 Osteosarcoma 1
 Mesothelioma 1
 Small-cell lung cancer 1
 Urothelial 1
 Unknown primary 1
Chemotherapy regimen
 Platinum agent + Gemcitabine 6
 Doxorubicin + Cyclophosphamide + Paclitaxel 4
 Platinum agent + Etoposide 2
 Cisplatin + Doxorubicin 1
 Capecitabine 1
 Carboplatin + Paclitaxel 1
 Cisplatin + Pemetrexed 1
 Oxaliplatin + Irinotecan +5FU 1
 Abraxane 1